X4 Pharmaceuticals Inc. (XFOR) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    X4 Pharmaceuticals Inc.

    NASDAQ: XFOR · Real-Time Price · USD
    3.48
    0.00 (0.00%)
    At close: Oct 03, 2025, 3:59 PM
    3.52
    1.04%
    After-hours: Oct 03, 2025, 05:27 PM EDT

    X4 Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 55.7M 99.22M 121.72M 81.79M
    Short-Term Investments
    		 46.36M 15M n/a n/a
    Long-Term Investments
    		 n/a 782K 1.02M 1.32M
    Other Long-Term Assets
    		 2.08M 654K 1.23M 1.72M
    Receivables
    		 1.71M 562K 1.15M 747K
    Inventory
    		 2.82M n/a n/a n/a
    Other Current Assets
    		 5.59M 7.3M 5.81M n/a
    Total Current Assets
    		 112.17M 122.08M 128.68M 87.88M
    Property-Plant & Equipment
    		 4.84M 6.39M 8.33M 10.22M
    Goodwill & Intangibles
    		 27.35M 17.35M 17.35M 17.35M
    Total Long-Term Assets
    		 34.27M 25.18M 26.91M 29.3M
    Total Assets
    		 146.45M 147.26M 155.59M 117.18M
    Account Payables
    		 8.62M 8.95M 7.78M 4.28M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a 1.1M 1.31M 795K
    Other Current Liabilities
    		 13.05M 7.1M 6.59M 5.42M
    Total Current Liabilities
    		 32.88M 22.86M 22.32M 14.02M
    Long-Term Debt
    		 75.42M 54.57M 32.3M 33.14M
    Other Long-Term Liabilities
    		 14.59M 16.11M 23.3M 826K
    Total Long-Term Liabilities
    		 91.42M 73.3M 59.21M 38.74M
    Total Liabilities
    		 124.3M 96.16M 81.53M 52.76M
    Total Debt
    		 78.09M 58.28M 38.42M 39.78M
    Book Value
    		 22.15M 51.1M 74.05M 64.41M
    Book Value Per Share
    		 3.30 8.62 35.92 86.84
    Common Stock
    		 171K 167K 122K 28K
    Retained Earnings
    		 -515.36M -477.9M -376.74M -282.87M
    Comprehensive Income
    		 -122K -119K -119K -119K
    Shareholders Equity
    		 22.15M 51.1M 74.05M 64.41M
    Total Investments
    		 46.36M 15M 1.02M 1.32M

    Add to Watchlist